Released July 31, 2020 | New Delhi
en
In a bid to boost research and development (R&D) in its pharmaceutical sector, Indian authorities are preparing a committee that will develop public policy for the discovery of novel drugs.
India has the third-largest pharmaceutical market in the world by volume, but it is in the 13th position according to economic value. The new policy will aim to add value by promoting research on novel molecules.
India's pharmaceutical sector, which is dominated primarily by generic medicines, recently has earned accolades for its novel discoveries. Indian firms have played a leading role in the development of indigenous vaccines, diagnostics and medication for COVID-19.
Industrial Info is tracking 65 COVID-19-related projects, worth more than $376 million, in India. Click here for a list, and see graph below for a breakdown by project type.
India has the third-largest pharmaceutical market in the world by volume, but it is in the 13th position according to economic value. The new policy will aim to add value by promoting research on novel molecules.
India's pharmaceutical sector, which is dominated primarily by generic medicines, recently has earned accolades for its novel discoveries. Indian firms have played a leading role in the development of indigenous vaccines, diagnostics and medication for COVID-19.
Industrial Info is tracking 65 COVID-19-related projects, worth more than $376 million, in India. Click here for a list, and see graph below for a breakdown by project type.
